Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content
In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...
Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...
Periodic Safety Update Report (PSUR): A Breakdown of MDCG 2022-21
A well-structured, clear, and concise PSUR enables a seamless notified body review. Read our key...
Clinical Evidence: How Much Is Enough?
Ensuring the safety and functionality of your medical device is vital. But how much clinical...
Digital Scientific Content: Stakeholder Perspectives
What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...
EU MDR: Increasing Expectations for Clinical Evidence
While the global medical devices industry is closely watching how the European Union (EU) Medical...
- 1
- 2